NCT00489658View on ClinicalTrials.gov

Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda

PHASE2/PHASE3TerminatedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

October 31, 2002

Conditions

Trypanosomiasis, African

Interventions

DRUG

Eflornithine plus Nifurtimox combination therapy

Trial Locations (1)

Unknown

Yumbe District Hospital, Yumbe

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Médecins Sans Frontières, France

OTHER

lead

Epicentre

OTHER

NCT00489658 - Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda | Biotech Hunter | Biotech Hunter